Thrombotic thrombocytopenic purpura in two patients with systemic lupus erythematosus: clinical significance of anti-platelet antibodies. 1990

Y Itoh, and H Sekine, and O Hosono, and T Takeuchi, and J Koide, and M Takano, and T Abe
The 2nd Department of Internal Medicine, Saitama Medical Center, Japan.

Thrombotic thrombocytopenic purpura (TTP) is a clinical syndrome of unknown etiology and has a high mortality rate due to disseminated platelet thrombi. However, the mechanism of platelet agglutination is not understood. Although an immunological mechanism has been suggested as the basis for the pathogenesis of TTP, any possible immune-mediated etiology remains unclear. The association of TTP with systemic lupus erythematosus (SLE) affords a unique opportunity to study such possibilities, because SLE is a prototype of autoimmune disease. This report describes two patients with SLE who developed TTP. The development of anti-platelet antibodies is one possible immunological mechanism for platelet agglutination in patients with SLE complicated by TTP. More importantly, patient J.Y., who had anti-platelet antibodies, responded dramatically to high doses of prednisolone.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011697 Purpura, Thrombotic Thrombocytopenic An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE. Mutations in the ADAMTS13 PROTEIN gene have been identified in familial cases. Moschkowitz Disease,Purpura, Thrombotic Thrombopenic,Thrombotic Thrombocytopenic Purpura, Congenital,Thrombotic Thrombocytopenic Purpura, Familial,Congenital Thrombotic Thrombocytopenic Purpura,Familial Thrombotic Thrombocytopenia Purpura,Familial Thrombotic Thrombocytopenic Purpura,Microangiopathic Hemolytic Anemia, Congenital,Moschcowitz Disease,Schulman-Upshaw Syndrome,Thrombotic Microangiopathy, Familial,Thrombotic Thrombocytopenic Purpura,Upshaw Factor, Deficiency of,Upshaw-Schulman Syndrome,Familial Thrombotic Microangiopathy,Microangiopathy, Familial Thrombotic,Schulman Upshaw Syndrome,Thrombocytopenic Purpura, Thrombotic,Thrombopenic Purpura, Thrombotic,Thrombotic Thrombopenic Purpura,Upshaw Schulman Syndrome
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).

Related Publications

Y Itoh, and H Sekine, and O Hosono, and T Takeuchi, and J Koide, and M Takano, and T Abe
June 2008, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology,
Y Itoh, and H Sekine, and O Hosono, and T Takeuchi, and J Koide, and M Takano, and T Abe
July 2003, The Journal of the Association of Physicians of India,
Y Itoh, and H Sekine, and O Hosono, and T Takeuchi, and J Koide, and M Takano, and T Abe
January 2007, European journal of dermatology : EJD,
Y Itoh, and H Sekine, and O Hosono, and T Takeuchi, and J Koide, and M Takano, and T Abe
January 2006, Acta haematologica,
Y Itoh, and H Sekine, and O Hosono, and T Takeuchi, and J Koide, and M Takano, and T Abe
March 1992, Annals of the rheumatic diseases,
Y Itoh, and H Sekine, and O Hosono, and T Takeuchi, and J Koide, and M Takano, and T Abe
March 1966, California medicine,
Y Itoh, and H Sekine, and O Hosono, and T Takeuchi, and J Koide, and M Takano, and T Abe
June 1964, Archives of internal medicine,
Y Itoh, and H Sekine, and O Hosono, and T Takeuchi, and J Koide, and M Takano, and T Abe
January 1994, Medicina clinica,
Y Itoh, and H Sekine, and O Hosono, and T Takeuchi, and J Koide, and M Takano, and T Abe
January 2001, Scandinavian journal of rheumatology,
Y Itoh, and H Sekine, and O Hosono, and T Takeuchi, and J Koide, and M Takano, and T Abe
April 1986, Annals of the rheumatic diseases,
Copied contents to your clipboard!